{"id":274,"date":"2026-08-22T05:03:42","date_gmt":"2026-08-22T05:03:42","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/value-oral-surgery-practice-2026\/"},"modified":"2026-08-22T05:03:42","modified_gmt":"2026-08-22T05:03:42","slug":"value-oral-surgery-practice-2026","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/value-oral-surgery-practice-2026\/","title":{"rendered":"How to Value an Oral Surgery Practice for Sale in 2026"},"content":{"rendered":"<h2 id=\"key-takeaways\">Key Valuation Drivers for Oral Surgery Practices in 2026<\/h2>\n<ul>\n<li>Practice value in 2026 is shaped by normalized EBITDA, referral durability, procedure mix, and buyer competition rather than a simple collections percentage.<\/li>\n<li>EBITDA multiples remain the standard for DSO and private equity deals, while collections-based valuations are still common in doctor-to-doctor sales.<\/li>\n<li>Three years of reconciled financials plus oral-surgery-specific add-backs can support a valuation that holds up during buyer diligence.<\/li>\n<li>Referral-base stability, procedure-mix concentration, and owner dependence can directly influence the multiple a practice receives.<\/li>\n<li>McLerran &amp; Associates provides side-by-side doctor-to-doctor and DSO valuations and can help you strengthen your position in the market, <a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">request a confidential discovery call today<\/a>.<\/li>\n<\/ul>\n<h2>Comparing Collections Percentage and EBITDA Multiple for Oral Surgery<\/h2>\n<p>Two valuation methods dominate dental practice transactions. The collections-percentage method expresses value as a share of trailing revenue and is most common in doctor-to-doctor sales. The EBITDA multiple method, where EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and reflects operating profit before non-cash and financing charges, is the standard for DSO and private equity transactions. The table below summarizes how each method applies to oral surgery practices in 2026.<\/p>\n<table>\n<thead>\n<tr>\n<th>Method<\/th>\n<th>Typical Application<\/th>\n<th>2026 Oral Surgery Range<\/th>\n<th>Key Limitation<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Collections Percentage<\/td>\n<td>Doctor-to-doctor sales, SBA-financed buyers<\/td>\n<td><a href=\"https:\/\/dentalpracticeloanguide.com\/learn\/dental-practice-valuation\" target=\"_blank\" rel=\"noindex nofollow\">80\u2013100% of trailing 12-month collections<\/a><\/td>\n<td>Ignores profit margin, so two practices with identical revenue but different cost structures receive the same value<\/td>\n<\/tr>\n<tr>\n<td>EBITDA Multiple<\/td>\n<td>DSO and private equity transactions<\/td>\n<td>Ranges vary by EBITDA scale, and platform deals can reach the higher end of the specialty band<\/td>\n<td>Requires well-documented normalization, and weak add-backs often collapse under buyer scrutiny<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Running both methods in parallel and reconciling them to a single offer range can produce a more defensible asking price than relying on either method alone. McLerran &amp; Associates includes both analyses as part of every engagement.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Explore which valuation approach fits your practice by requesting a confidential call with McLerran &amp; Associates<\/a>.<\/p>\n<h2>How Buyers Typically Value Oral Surgery Practices<\/h2>\n<p>Most buyers value oral surgery practices by normalizing three years of financial statements into adjusted EBITDA, applying a market multiple that reflects the practice\u2019s size, specialty, and risk profile, and then stress-testing that number against the review a buyer\u2019s quality-of-earnings team will perform. This approach is more rigorous than a collections-percentage estimate because oral surgery profit margins can vary significantly based on procedure mix, anesthesia capabilities, and staffing structure, which a revenue-only metric cannot capture.<\/p>\n<p><a href=\"https:\/\/beckersdental.com\/dentists\/the-shifting-oral-surgery-landscape\" target=\"_blank\" rel=\"noindex nofollow\">Recent deal activity in oral surgery has outpaced other dental specialties<\/a>, and <a href=\"https:\/\/www.beckersdental.com\/benchmarking\/16-of-us-dentists-affiliated-with-a-dso-state-by-state-breakdown\/\" target=\"_blank\" rel=\"noindex nofollow\">DSO affiliation among U.S. dentists grew from 7.2% in 2015 to 16.1% in 2024<\/a>. As consolidation increases, more sophisticated buyers review practices, and valuations that cannot withstand institutional diligence are often re-traded after the letter of intent is signed.<\/p>\n<h2>Step 1: Gather Three Years of Financial Statements<\/h2>\n<p>A defensible valuation usually starts with three consecutive years of profit-and-loss statements and the corresponding business tax returns. Three years of data allow an advisor to identify trends such as growing or declining collections, shifting expense ratios, and one-time costs, and to separate recurring profitability from anomalies. Buyers typically view three years of consistent or improving results as more persuasive than a single strong year.<\/p>\n<p>The tax return and the P&amp;L should reconcile. Discrepancies between what was reported to the IRS and what appears on internal financials are among the first items a buyer\u2019s quality-of-earnings team will flag. Clean, reconciled financials assembled before going to market can prevent surprises that compress value during diligence.<\/p>\n<h2>Step 2: Normalize EBITDA with Oral-Surgery-Specific Adjustments<\/h2>\n<p>Normalization adjusts reported net income to reflect the recurring cash flow a new owner could reasonably expect. For oral surgery practices, this process includes both standard add-backs and specialty-specific adjustments. The table below illustrates how normalization can work in practice.<\/p>\n<table>\n<thead>\n<tr>\n<th>Line Item<\/th>\n<th>Reported Amount (Example)<\/th>\n<th>Normalized Adjustment<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Owner compensation (total W-2 + distributions)<\/td>\n<td>$600,000<\/td>\n<td>Replace with market-rate associate cost of 35\u201340% of net collections for oral surgery, and add back the difference<\/td>\n<\/tr>\n<tr>\n<td>Personal vehicle expense run through practice<\/td>\n<td>$24,000<\/td>\n<td>Add back in full as personal or discretionary<\/td>\n<\/tr>\n<tr>\n<td>Family member payroll (non-productive)<\/td>\n<td>$90,000<\/td>\n<td>Add back in full<\/td>\n<\/tr>\n<tr>\n<td>One-time leasehold improvement (non-recurring)<\/td>\n<td>$40,000<\/td>\n<td>Add back with documentation that it will not recur<\/td>\n<\/tr>\n<tr>\n<td>Depreciation and amortization<\/td>\n<td>Varies<\/td>\n<td>Standard EBITDA add-back, treated as a hard add-back when properly documented<\/td>\n<\/tr>\n<tr>\n<td>Below-market rent (owner-owned building)<\/td>\n<td>Varies<\/td>\n<td>Normalize to market rent of approximately 5\u20138% of collections, with below-market rent creating a negative adjustment<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Several adjustments require particular care in oral surgery. Owner compensation normalization is often the single largest adjustment, and understating the replacement cost of a high-producing oral surgeon can inflate EBITDA and create a number that will not survive scrutiny. Beyond owner compensation, recurring expenses such as continuing education, professional dues, and marketing spend are frequently challenged by buyers because they represent ongoing operating costs rather than true one-time items. After all adjustments are made, a well-run dental practice often targets approximately 25% EBITDA margin after normalizing owner compensation to associate-equivalent cost, which many buyers use as a benchmark and a basic check on the normalization work.<\/p>\n<h2>Step 3: Evaluate Referral-Base Stability and Procedure Mix<\/h2>\n<p>Once you have established a normalized EBITDA baseline, the next step is to assess the qualitative factors that influence which multiple buyers apply to that baseline. For oral surgery practices, referral-base stability and procedure mix can be some of the most consequential value drivers and some of the most scrutinized. A practice whose revenue depends on two or three referring general dentists carries a different risk profile than one with relationships spread across 30 or more referring providers, and buyers often price that risk directly into the multiple they offer.<\/p>\n<p>The checklist below highlights the referral and procedure-mix factors that buyers and their advisors commonly evaluate during diligence.<\/p>\n<table>\n<thead>\n<tr>\n<th>Factor<\/th>\n<th>What Buyers Assess<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Referral source count<\/td>\n<td>Geographic proximity and density of referring general dentists, pediatric dentists, and orthodontists<\/td>\n<\/tr>\n<tr>\n<td>Referral concentration<\/td>\n<td>Percentage of revenue from the top 3 and top 10 referring providers, with high concentration increasing transition risk<\/td>\n<\/tr>\n<tr>\n<td>Referral tenure<\/td>\n<td>Length and consistency of referral relationships, with multi-year relationships viewed as more defensible<\/td>\n<\/tr>\n<tr>\n<td>Procedure mix<\/td>\n<td>Volume of implants, third-molar extractions, bone grafting, and trauma or medically indicated procedures<\/td>\n<\/tr>\n<tr>\n<td>Anesthesia capabilities<\/td>\n<td>In-house anesthesia that supports expanded procedure eligibility, lower cancellation rates, and higher throughput<\/td>\n<\/tr>\n<tr>\n<td>Owner dependence<\/td>\n<td>Percentage of revenue produced by the selling doctor, with practices where the owner produces 90% of revenue presenting meaningful transition risk<\/td>\n<\/tr>\n<tr>\n<td>Associate provider depth<\/td>\n<td>Impact of adding even one producing associate, which can move an owner-dependent practice up by approximately one full turn of EBITDA multiple<\/td>\n<\/tr>\n<tr>\n<td>Payer mix<\/td>\n<td>Ratio of fee-for-service to insurance, with low exposure to government reimbursement often supporting higher multiples<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Enterprise goodwill supported by stable referral sources and associate providers tends to transfer more readily to buyers than personal goodwill attached to the founding surgeon, and this distinction can directly affect the multiple a practice commands.<\/p>\n<h2>Step 4: Apply 2026 Market Ranges for Oral Surgery and General Dentistry<\/h2>\n<p>Oral surgery has consistently commanded a premium over general dentistry in both collections-based and EBITDA-based valuations. This premium reflects higher per-procedure revenue, anesthesia capabilities, and stronger buyer competition from specialty-focused platforms. Given the increased buyer interest in the specialty mentioned earlier, EBITDA scale remains a primary driver of the multiple achieved, with meaningful step-ups at key EBITDA thresholds.<\/p>\n<p>Dental practice multiples have moderated from the peak levels of 2021\u20132023 but remain attractive as of mid-2026. At the same time, some sellers remain anchored to peak 2021 pricing while buyers recalibrate for a higher-cost, higher-risk environment, and a competitive, advisor-run process can help close that gap. <a href=\"https:\/\/beckersdental.com\/featured-perspectives\/what-the-next-phase-of-dental-ma-will-look-like\" target=\"_blank\" rel=\"noindex nofollow\">Leaders at large oral surgery consolidators have indicated that lower interest rates and pent-up demand may bring more groups to the table and create additional partnership opportunities in 2026<\/a>.<\/p>\n<h2>Step 5: Compare Doctor-to-Doctor and DSO Sale Outcomes<\/h2>\n<p>Most oral surgery practice owners benefit from comparing what each transition path can deliver. That comparison usually includes not only the headline multiple, but also the after-tax cash in hand, the equity retained, and the projected economic outcome over 3, 5, and 10 years.<\/p>\n<table>\n<thead>\n<tr>\n<th>Dimension<\/th>\n<th>Doctor-to-Doctor Sale<\/th>\n<th>DSO \/ Private Equity Affiliation<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Valuation basis<\/td>\n<td>Collections percentage, constrained by the individual buyer\u2019s SBA or conventional financing capacity<\/td>\n<td>Adjusted EBITDA multiple, with institutional capital supporting higher multiples for larger practices<\/td>\n<\/tr>\n<tr>\n<td>Deal structure<\/td>\n<td>Typically all-cash or near-all-cash at close, with no equity rollover<\/td>\n<td>Often 60\u201385% cash at close, 10\u201330% rollover equity, 1\u20133 year earnout, and an indemnification escrow<\/td>\n<\/tr>\n<tr>\n<td>Post-sale work requirement<\/td>\n<td>Typically a 4\u20136 month transition, with a walk-away exit possible<\/td>\n<td>Typically a 3\u20135 year employment agreement, often with EBITDA maintenance requirements<\/td>\n<\/tr>\n<tr>\n<td>Equity upside<\/td>\n<td>No equity upside after closing<\/td>\n<td>Potential for up to approximately 40% of deal value in DSO equity and possible multiple expansion at recapitalization<\/td>\n<\/tr>\n<tr>\n<td>Clinical autonomy<\/td>\n<td>High, because the buyer is also a clinician<\/td>\n<td>Varies by platform and is typically negotiated in the letter of intent<\/td>\n<\/tr>\n<tr>\n<td>Timeline to close<\/td>\n<td>Typically 4\u20136 months<\/td>\n<td>Typically 6\u20139 months from valuation to close<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Because McLerran &amp; Associates works both transition paths in roughly equal measure across its completed transactions, the firm can provide a genuine side-by-side comparison rather than steering owners toward a single preferred path. That comparison often becomes the foundation of an informed decision.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Request a side-by-side valuation review to see how doctor-to-doctor and DSO paths compare for your practice<\/a>.<\/p>\n<h2>Step 6: Prepare the Buyer-Requested Document Package<\/h2>\n<p>Before a qualified buyer submits a letter of intent, they usually request a standard document package. Preparing this package in advance, rather than scrambling during diligence, can signal operational maturity and prevent delays that cause deals to stall. The core documents buyers often request for oral surgery practices include the following.<\/p>\n<ul>\n<li>Three years of business tax returns (Form 1120-S or Schedule C)<\/li>\n<li>Three years of monthly profit-and-loss statements<\/li>\n<li>Current accounts-receivable aging report, with buyers often flagging AR concentrations over 90 days<\/li>\n<li>Trailing 12-month collections by procedure code and payer<\/li>\n<li>Current lease agreement and any renewal options<\/li>\n<li>Equipment list with age and maintenance records<\/li>\n<li>Associate and staff compensation schedules<\/li>\n<li>Referral source list with volume by provider, anonymized for initial marketing<\/li>\n<li>Anesthesia permits and compliance documentation<\/li>\n<li>Any pending litigation or regulatory matters<\/li>\n<\/ul>\n<p>Institutional buyers often treat documentation gaps as risk factors that justify downward adjustments to EBITDA. A well-organized data room can accelerate diligence and reduce the leverage buyers have to re-trade the agreed price, but even strong documentation usually needs to be paired with a valuation that can withstand deeper review.<\/p>\n<h2>Step 7: Stress-Test the Valuation with a Quality-of-Earnings Checklist<\/h2>\n<p>A quality-of-earnings review, often called a QoE, is the process by which a buyer\u2019s accounting team independently verifies the normalized EBITDA the seller has presented. For oral surgery practices transacting with DSOs or private equity buyers, a QoE is standard, and sellers who stress-test their numbers in advance are often better prepared for this stage. The checklist below highlights the areas that buyers most commonly challenge.<\/p>\n<ul>\n<li><strong>Owner compensation normalization:<\/strong> Buyers verify that the replacement-doctor cost reflects actual market rates for an oral surgeon, not a general dentist.<\/li>\n<li><strong>Recurring vs. one-time expenses:<\/strong> Add-backs that appear consistently across three years of P&amp;Ls are usually treated as recurring operating expenses, not one-time items.<\/li>\n<li><strong>Marketing spend normalization:<\/strong> Unsustainably low marketing spend, such as below approximately 2\u20133% of revenue, may result in a downward EBITDA adjustment to reflect the cost a new owner would need to sustain referral volume.<\/li>\n<li><strong>Related-party transactions:<\/strong> Above- or below-market rent paid to a related entity, family payroll, and management fees often require independent market comparisons.<\/li>\n<li><strong>AR quality:<\/strong> Concentrations of receivables over 90 days are often treated as phantom EBITDA, meaning profit that appears real on the P&amp;L but may not be collectible.<\/li>\n<li><strong>Staff compensation benchmarking:<\/strong> Below-market staff pay can create post-close retention risk and may result in a negative EBITDA adjustment.<\/li>\n<\/ul>\n<p>McLerran &amp; Associates typically performs this stress-test before the practice goes to market, rather than after the LOI is signed. That upfront rigor can help valuations hold under buyer scrutiny and reduce the likelihood that deals are re-traded during diligence.<\/p>\n<h2>Estimating What an Oral Surgery Practice May Be Worth<\/h2>\n<p>The value of a specific oral surgery practice usually depends on its normalized EBITDA, its EBITDA scale relative to market thresholds, its referral-base stability, its procedure mix, its provider depth, and the competitive tension created when multiple qualified buyers bid at the same time. EBITDA scale can be a primary driver of the multiple achieved, with incremental EBITDA growth often producing valuation step-ups at key thresholds.<\/p>\n<p>General ranges reported in 2026 market data can provide orientation. Specialty practices including oral surgery often command higher multiples than single-doctor general practices in DSO transactions, and oral surgery groups with multi-million-dollar EBITDA can trade at a structural premium of 20\u201340% over general dentistry multiples because of referral-driven revenue and high margins. These ranges serve as starting points rather than guarantees, and the specific number a practice achieves usually depends on the quality of the valuation work and the breadth of the buyer process.<\/p>\n<h2>Setting an Asking Price for an Oral Surgery Practice<\/h2>\n<p>Pricing an oral surgery practice for sale typically requires three inputs. These include a defensible normalized EBITDA figure, a market multiple that fits the practice\u2019s size and characteristics, and a competitive process that prevents any single buyer from anchoring the price below market. An asking price set too high without supporting analysis can cause qualified buyers to disengage, while a price set too low, or one set by a buyer through a \u201cfree\u201d valuation, can leave value on the table permanently.<\/p>\n<p>Sellers who negotiate directly with a single DSO often have expectations based on peak-era deals, while buyers may be recalibrating for a higher-cost environment. A structured, multi-buyer process can reveal what the current market will actually pay. McLerran &amp; Associates runs an auction-style process that typically generates around 10 offers within 45\u201360 days, which can create the competitive tension that pushes price and terms toward the seller\u2019s favor. The firm\u2019s clients have reported achieving higher valuations on average than owners who sell without representation.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Discuss a data-driven pricing strategy for your oral surgery practice with McLerran &amp; Associates<\/a>.<\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the difference between EBITDA normalization and a collections-based valuation for an oral surgery practice?<\/h3>\n<p>A collections-based valuation expresses practice value as a percentage of total revenue collected over the trailing 12 months. This method is straightforward to calculate but ignores profitability, so two practices with identical collections but very different cost structures receive the same value. EBITDA normalization starts with reported net income and adds back non-cash charges, financing costs, and owner-specific expenses to estimate the operating profit a new owner could reasonably expect. For oral surgery practices, which often have higher revenue per procedure and more variable cost structures than general dentistry, the EBITDA method can produce a more accurate and defensible value, particularly in DSO and private equity transactions where institutional buyers underwrite primarily on adjusted EBITDA. McLerran &amp; Associates typically builds both analyses for every engagement and reconciles them to a single defensible asking price.<\/p>\n<h3>How does owner dependence affect the value of my oral surgery practice?<\/h3>\n<p>Owner dependence describes how much revenue and how many patient relationships are tied to the founding surgeon rather than the practice as a business. Buyers often view a practice where the selling doctor produces the large majority of revenue as higher risk, because patients and referring dentists may follow the departing surgeon instead of staying with the practice. That risk is usually reflected in the multiple buyers offer, which can mean a lower valuation for a highly owner-dependent practice compared to one with associate providers who share production across the team. Adding even one producing associate before going to market can improve transferability and support a stronger multiple. McLerran &amp; Associates evaluates owner dependence as part of each valuation and can suggest steps that may strengthen the practice\u2019s position before it is listed.<\/p>\n<h3>What should I expect from a DSO deal structure for an oral surgery practice?<\/h3>\n<p>DSO transactions for oral surgery practices are rarely all-cash purchases. A standard 2026 structure often includes a cash payment at closing that represents most of the purchase price, a rollover equity component where the seller retains an ownership stake in the acquiring DSO or its parent entity, a performance-based earnout tied to EBITDA or collections targets over one to three years, and an indemnification escrow held for 12 to 24 months. The equity component, which can represent a meaningful share of total deal value, effectively makes the selling surgeon an investor in the DSO, so that investment usually deserves careful review. Many sellers consider questions such as whether the DSO is profitable, whether its revenue is growing, and whether its private equity backer is well-capitalized and experienced. McLerran &amp; Associates reviews buyers with this investment lens and has blacklisted DSOs known for poor post-close environments, guiding clients toward well-backed partners with a stronger track record.<\/p>\n<h3>How long does it take to sell an oral surgery practice?<\/h3>\n<p>The timeline usually depends on the transition path. A doctor-to-doctor sale of an oral surgery practice typically runs four to six months from listing to closing, followed by a short work-back period of several weeks before the seller exits. A DSO or private equity transaction typically runs six to nine months from the initial valuation through closing, reflecting the additional complexity of institutional diligence, legal documentation, and deal structuring. McLerran &amp; Associates\u2019 auction-style DSO process often generates offers within 45 to 60 days of going to market, which can compress the front end of the timeline while maintaining competitive tension. Owners who are not yet ready to sell can request a complimentary valuation update one year later at no charge, which can reduce pressure to move before the timing feels right.<\/p>\n<h3>Why does McLerran &amp; Associates charge for its valuation when other firms offer free valuations?<\/h3>\n<p>Many free valuations function as lead-generation tools and provide a quick estimate designed to attract a listing rather than withstand institutional scrutiny. When a buyer\u2019s quality-of-earnings team reviews a weakly supported valuation, the agreed price can be re-traded downward during diligence, sometimes by significant amounts. McLerran &amp; Associates builds a CPA-led, diligence-grade EBITDA analysis before the practice goes to market, aiming to create a work product that holds up when sophisticated buyers review the details. The firm\u2019s transaction rate, which has historically exceeded broader industry averages, reflects the difference between a practice that is carefully prepared for sale and one that is simply listed. In one documented case, a free valuation placed a practice at $2.5 million, while McLerran\u2019s analysis valued it at $4.5 million, and the practice ultimately sold for $5.25 million after a competitive process.<\/p>\n<h2>Conclusion: Using a Structured Framework to Prepare for Sale<\/h2>\n<p>Valuing an oral surgery practice for sale in 2026 can be approached as a seven-step process. These steps include assembling three years of clean financials, normalizing EBITDA with oral-surgery-specific add-backs, quantifying referral-base stability and procedure-mix quality, applying current market ranges, running a side-by-side doctor-to-doctor and DSO comparison, assembling the buyer-requested document package, and stress-testing the result against quality-of-earnings scrutiny. Each step builds on the last, and a weakness at any point, such as an unsupported add-back, an undocumented referral concentration, or a missing lease document, can compress the final number or cause a deal to fall apart.<\/p>\n<p>McLerran &amp; Associates has guided practice owners through this process for roughly 35 years, completing approximately 2,000 successful transactions that represent close to $2 billion in closed volume. The firm evaluates more than 500 practices per year, works both the doctor-to-doctor and DSO paths in roughly equal measure, and operates as a sell-side-only advocate, so its incentives align with the selling doctor rather than the buyer. With the heightened DSO acquisition activity noted earlier and <a href=\"https:\/\/beckersdental.com\/featured-perspectives\/what-the-next-phase-of-dental-ma-will-look-like\" target=\"_blank\" rel=\"noindex nofollow\">buyers increasingly prioritizing practices with strong systems, operational maturity, and consistent performance<\/a>, the window for well-prepared oral surgery practices appears open, and preparation can be a key prerequisite.<\/p>\n<p><a href=\"https:\/\/dentaltransitions.com\/contact-us\/\" target=\"_blank\">Connect with McLerran &amp; Associates to discuss your practice, your goals, and what a defensible 2026 valuation could look like for your situation<\/a>. Call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com\/contact-us.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Discover how EBITDA multiples and referral strength shape oral surgery practice value. McLerran provides expert valuations \u2014 request yours today.<\/p>\n","protected":false},"author":1,"featured_media":273,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-274","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/274","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=274"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/274\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/273"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=274"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=274"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=274"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}